International Stem Cell Corp. (ISCO) Scheduled to Present at the Biotech Showcase 2013 Conference
International Stem Cell Corp., a biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today announced that Executive Vice President, Dr. Simon Craw, will be presenting at the Biotech Showcase™ 2013 conference early next week. The event is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel.
Date: Monday, January 7, 2013
Time: 9:30 pm PST
Location: Parc 55 Wyndham Union Square Hotel, San Francisco, CA
Room: Room Mission II – Track C
Those who wish to attend the conference or arrange a meeting with ISCO’s management team should contact the conference organizers. To register for the event, visit the conference Web site at www.ebdgroup.com/bts/registration/index.php.
Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event. For more information, please visit the conference Web site at www.ebdgroup.com/bts/index.php.
The investor presentation delivered at the Biotech Showcase conference will be available on the investor relations section of ISCO’s Web site at www.internationalstemcell.com.
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net